An update on larynx cancer

DOI Web Site Web Site 4 Citations
  • Conor E. Steuer
    Assistant Professor, Department of Hematology Oncology Winship Cancer Institute of Emory University Atlanta GA
  • Mark El‐Deiry
    Associate Professor, Department of Otolaryngology Winship Cancer Institute of Emory University Atlanta GA
  • Jason R. Parks
    Resident, Department of Radiation Oncology Winship Cancer Institute of Emory University Atlanta GA
  • Kristin A. Higgins
    Assistant Professor, Department of Radiation Oncology Winship Cancer Institute of Emory University Atlanta GA
  • Nabil F. Saba
    Professor and Director of the Head and Neck Medical Oncology Program, Department of Hematology Oncology Winship Cancer Institute of Emory University Atlanta GA

Abstract

<jats:title>Abstract</jats:title><jats:p><jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.wileyhealthlearning.com/acs.aspx">Answer questions and earn CME/CNE</jats:ext-link></jats:p><jats:p>Laryngeal cancer remains one of the most common tumors of the respiratory tract. Fortunately, significant advancements have been made over the past decade in the treatment of laryngeal cancer. Although surgery has been the historical mainstay for localized disease and still is an integral part of treatment, nonsurgical options like radiation and systemic therapy have emerged as viable options. In addition, in the metastatic setting, novel agents are showing promise for this patient population. The care for patients with laryngeal cancer continues to evolve and truly requires a multidisciplinary team‐based approach. Unique morbidities, such as loss of natural voice, respiration, and airway protection during swallowing, are observed with this disease and require special consideration. <jats:bold>CA Cancer J Clin 2017;67:31–50. © 2016 American Cancer Society.</jats:bold></jats:p>

Journal

Citations (4)*help

See more

Report a problem

Back to top